Cargando…
FDG-PET/CT in the Assessment of Treatment Response after Oncologic Treatment of Head and Neck Squamous Cell Carcinoma
BACKGROUND: In many centers, (18)F-fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) is used to monitor treatment response after definitive (chemo)radiotherapy [(C)RT] for head and neck squamous cell carcinoma (HNSCC), but its usefulness remains somewhat controversial....
Autores principales: | Keski-Säntti, Harri, Mustonen, Timo, Schildt, Jukka, Saarilahti, Kauko, Mäkitie, Antti A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149379/ https://www.ncbi.nlm.nih.gov/pubmed/25210484 http://dx.doi.org/10.4137/CMENT.S16399 |
Ejemplares similares
-
Management of clinically N0 neck in oropharyngeal carcinoma
por: Jouhi, Lauri, et al.
Publicado: (2019) -
A Novel Digital Patient-Reported Outcome Platform for Head and Neck Oncology Patients—A Pilot Study
por: Peltola, Maria K., et al.
Publicado: (2016) -
Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma: Association with Metabolic Tumor Burden Determined with FDG-PET/CT
por: Silvoniemi, Antti, et al.
Publicado: (2023) -
Nutritional Counseling for Head and Neck Cancer Patients Undergoing (Chemo) Radiotherapy—A Prospective Randomized Trial
por: Orell, Helena, et al.
Publicado: (2019) -
Hypopharyngeal carcinoma in Finland from 2005 to 2014: outcome remains poor after major changes in treatment
por: Keski-Säntti, Harri, et al.
Publicado: (2022)